XML 50 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Identifiable Intangible Assets and Goodwill (Tables)
6 Months Ended
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
The following table provides the components of Identifiable intangible assets:
 
 
June 30, 2019
 
December 31, 2018
(MILLIONS OF DOLLARS)
 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

Finite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Developed technology rights
 
$
89,540

 
$
(60,949
)
 
$
28,590

 
$
89,430

 
$
(58,895
)
 
$
30,535

Brands
 
923

 
(725
)
 
198

 
923

 
(708
)
 
215

Licensing agreements and other
 
1,440

 
(1,159
)
 
281

 
1,436

 
(1,140
)
 
296

 
 
91,903

 
(62,833
)
 
29,070

 
91,788

 
(60,743
)
 
31,045

Indefinite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Brands and other
 
1,994

 


 
1,994

 
1,994

 


 
1,994

IPR&D
 
1,961

 


 
1,961

 
2,171

 


 
2,171

 
 
3,954

 


 
3,954

 
4,165

 


 
4,165

Identifiable intangible assets(a)
 
$
95,857

 
$
(62,833
)
 
$
33,024

 
$
95,954

 
$
(60,743
)
 
$
35,211


(a) 
The decrease in Identifiable intangible assets, less accumulated amortization, is primarily due to amortization and intangible asset impairment charges, partially offset by additions for the period. See Note 4 for additional information on intangible asset impairments.
Schedule of Indefinite Lived Intangible Assets
The following table provides the components of Identifiable intangible assets:
 
 
June 30, 2019
 
December 31, 2018
(MILLIONS OF DOLLARS)
 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

Finite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Developed technology rights
 
$
89,540

 
$
(60,949
)
 
$
28,590

 
$
89,430

 
$
(58,895
)
 
$
30,535

Brands
 
923

 
(725
)
 
198

 
923

 
(708
)
 
215

Licensing agreements and other
 
1,440

 
(1,159
)
 
281

 
1,436

 
(1,140
)
 
296

 
 
91,903

 
(62,833
)
 
29,070

 
91,788

 
(60,743
)
 
31,045

Indefinite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Brands and other
 
1,994

 


 
1,994

 
1,994

 


 
1,994

IPR&D
 
1,961

 


 
1,961

 
2,171

 


 
2,171

 
 
3,954

 


 
3,954

 
4,165

 


 
4,165

Identifiable intangible assets(a)
 
$
95,857

 
$
(62,833
)
 
$
33,024

 
$
95,954

 
$
(60,743
)
 
$
35,211


(a) 
The decrease in Identifiable intangible assets, less accumulated amortization, is primarily due to amortization and intangible asset impairment charges, partially offset by additions for the period. See Note 4 for additional information on intangible asset impairments.
Identifiable Intangible Assets as a Percentage of Total Identifiable Intangible Assets Less Accumulated Amortization, By Segment
Our identifiable intangible assets are associated with the following, as a percentage of total identifiable intangible assets, less accumulated amortization:
 
 
June 30, 2019
 
 
Biopharma
 
Upjohn
 
WRDM
Developed technology rights
 
99
%
 
1
%
 

Brands, finite-lived
 
100
%
 

 

Brands, indefinite-lived
 
42
%
 
58
%
 

IPR&D
 
86
%
 

 
14
%

Schedule of Goodwill
The following table provides the components of and changes in the carrying amount of Goodwill:
(MILLIONS OF DOLLARS)
 
Biopharma
 
Upjohn
 
Total
Balance, December 31, 2018
 
$
42,927

 
$
10,484

 
$
53,411

Other(a)
 
(47
)
 
(12
)
 
(59
)
Balance, June 30, 2019
 
$
42,880

 
$
10,472

 
$
53,352


(a) 
Primarily reflects the impact of foreign exchange.